Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients

Critical Care Medicine

Volumn 40, Issue 12, 2012, Pages 3251-3276

  Jacobi, Judith ^a   Bircher, Nicholas ^b   Krinsley, James ^c   Agus, Michael ^d   Braithwaite, Susan S ^e   Deutschman, Clifford ^f   Freire, Amado X ^g   Geehan, Douglas ^h   Kohl, Benjamin ⁱ   Nasraway, Stanley A ^j   Rigby, Mark ^k   Sands, Karen ^l   Schallom, Lynn ^m   Taylor, Beth ^m   Umpierrez, Guillermo ⁿ   Mazuski, John ^o   Schunemann, Holger ^p  

^a INDIANA UNIVERSITY HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c STAMFORD HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e Endocrine Consults and Care   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j TUFTS MEDICAL CENTER   (United States)

^k RILEY HOSPITAL FOR CHILDREN   (United States)

^l Novant Health   (United States)

^m BARNES JEWISH HOSPITAL   (United States)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o WASHINGTON UNIVERSITY   (United States)

^p MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

critical care; glucose meter; glucose monitoring; glycemic control; guideline; hyperglycemia; insulin; protocol; stress hyperglycemia

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN; SHORT ACTING INSULIN;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CARBOHYDRATE DIET; CARDIOVASCULAR SURGERY; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COST OF ILLNESS; CRITICALLY ILL PATIENT; DRUG MONITORING; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HEALTH CARE UTILIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INTENSIVE CARE; INTENSIVE CARE UNIT; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NERVOUS SYSTEM INJURY; NUTRITIONAL SUPPORT; PATIENT SAFETY; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; TREATMENT DURATION;

CARDIOVASCULAR SURGICAL PROCEDURES; CRITICAL CARE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PRACTICE GUIDELINES AS TOPIC; TRAUMA, NERVOUS SYSTEM; WOUNDS AND INJURIES;

EID: 84870225739     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182653269     Document Type: Article

References (222)

1. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
2. Bagshaw SM, Egi M, George C, et al; Australia New Zealand Intensive Care Society Database Management Committee: Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009; 37:463-470
3. Falciglia M, Freyberg RW, Almenoff PL, et al: Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009; 37:3001-3009
4. Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group Web site. Available at: http://www. gradeworkinggroup.org. Accessed January 7, 2011
5. Review Manager (RevMan) [computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008. Available at: http://www. ims.cochrane.org/revman/about-revman-5. Accessed January 7, 2011
6. GRADEprofiler [computer program]. Available at: http://www.ims.cochrane. org/revman/gradepro. Accessed January 7, 2011
7. American Diabetes Association: Standards of medical care in diabetes-2012. Diabetes Care 2012; 35(Suppl 1):S11-S63
8. Umpierrez GE, Isaacs SD, Bazargan N, et al: Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982
9. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047
10. Freire AX, Bridges L, Umpierrez GE, et al: Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 2005; 128:3109-3116
11. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78: 1471-1478
12. de Azevedo JRA, de Araujo LE, da Silva WS, et al: A carbohydrate- restrictive strategy is safer and as efficient as intensive insulin therapy in critically ill patients. J Crit Care 2010; 25:84-89
13. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
14. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
15. Preiser JC, Devos P, Ruiz-Santana S, et al: A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol study. Intensive Care Med 2009; 35:1738-1748
16. The NICE-SUGAR Investigators: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297
17. Brunkhorst FM, Engel C, Bloos F, et al; German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
18. De La Rosa G, Donado JH, Restrepo AH, et al: Strict glycemic control in patients hospitalized in a mixed medical and surgical intensive care unit: A randomized clinical trial. Crit Care 2008; 12:R120
19. Arabi YM, Dabbagh OC, Tamim HM, et al: Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008; 36:3190-3197
20. Farah R, Samokhvalov A, Zviebel F, et al: Insulin therapy of hyperglycemia in intensive care. Isr Med Assoc J 2007; 9:140-142
21. Grey NJ, Perdrizet GA: Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004; 10(Suppl 2):46-52
22. Mackenzie IM, Ercole A, Blunt M, et al: Glycaemic control and outcome in general intensive care: The East Anglian GLYCOGENIC study. Br J Intensive Care 2008; 18:121-126
23. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000
24. Furnary AP, Gao G, Grunkemeier GL, et al: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-1021
25. Treggiari MM, Karir V, Yanez ND, et al: Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008; 12:R29
26. Krinsley JS: Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: Six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg 2006; 18:317-325
27. Scalea TM, Bochicchio GV, Bochicchio KM, et al: Tight glycemic control in critically injured trauma patients. Ann Surg 2007; 246:605-610; discussion 610
28. Furnary AP, Wu Y: Eliminating the diabetic disadvantage: The Portland Diabetic Project. Semin Thorac Cardiovasc Surg 2006; 18:302-308
29. Toft P, Jørgensen HS, Toennesen E, et al: Intensive insulin therapy to non-cardiac ICU patients: A prospective study. Eur J Anaesthesiol 2006; 23:705-709
30. Schultz MJ, Harmsen RE, Spronk PE: Clinical review: Strict or loose glycemic control in critically ill patients-Implementing best available evidence from randomized controlled trials. Crit Care 2010; 14:223
31. Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300: 933-944
32. Griesdale DE, de Souza RJ, van Dam RM, et al: Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821-827
33. Marik PE, Preiser JC: Toward understanding tight glycemic control in the ICU: A systematic review and metaanalysis. Chest 2010; 137:544-551
34. Ingels C, Debaveye Y, Milants I, et al: Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006; 27:2716-2724
35. Zerr KJ, Furnary AP, Grunkemeier GL, et al: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63:356-361
36. Furnary AP, Zerr KJ, Grunkemeier GL, et al: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-360; discussion 360
37. Leibowitz G, Raizman E, Brezis M, et al: Effects of moderate intensity glycemic control after cardiac surgery. Ann Thorac Surg 2010; 90:1825-1832
38. Schmeltz LR, DeSantis AJ, Thiyagarajan V, et al: Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007; 30:823-828
39. Heath DF: Glucose, insulin and other plasma metabolites shortly after injury. J Accid Emerg Med 1994; 11:67-77
40. Yendamuri S, Fulda GJ, Tinkoff GH: Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003; 55:33-38
41. Bochicchio GV, Bochicchio KM, Joshi M, et al: Acute glucose elevation is highly predictive of infection and outcome in critically injured trauma patients. Ann Surg 2010; 252:597-602
42. Sung J, Bochicchio GV, Joshi M, et al: Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 59:80-83
43. Vogelzang M, Nijboer JM, van der Horst IC, et al: Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients. J Trauma 2006; 60:873-877; discussion 878
44. Gale SC, Sicoutris C, Reilly PM, et al: Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg 2007; 73:454-460
45. Bochicchio GV, Sung J, Joshi M, et al: Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 58:921-924
46. Kao LS, Todd SR, Moore FA: The impact of diabetes on outcome in traumatically injured patients: An analysis of the National Trauma Data Bank. Am J Surg 2006; 192:710-714
47. Reed CC, Stewart RM, Sherman M, et al: Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg 2007; 204:1048-1054; discussion 1054
48. Collier B, Diaz J Jr, Forbes R, et al: The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. JPEN J Parenter Enteral Nutr 2005; 29:353-358; discussion 359
49. Melamed E: Reactive hyperglycaemia in patients with acute stroke. J Neurol Sci 1976; 29:267-275
50. Pentelényi T, Kammerer L, Stützel M, et al: Alterations of the basal serum insulin and blood glucose in brain-injured patients. Injury 1979; 10:201-208
51. Scott JF, Robinson GM, French JM, et al: Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 1999; 353:376-377
52. Kernan WN, Viscoli CM, Inzucchi SE, et al: Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 2005; 165:227-233
53. Allport L, Baird T, Butcher K, et al: Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 2006; 29:1839-1844
54. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001; 32:2426-2432
55. Bruno A, Levine SR, Frankel MR, et al; NINDS rt-PA Stroke Study Group: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59:669-674
56. Dimopoulou I, Kouyialis AT, Orfanos S, et al: Endocrine alterations in critically ill patients with stroke during the early recovery period. Neurocrit Care 2005; 3:224-229
57. Garg R, Chaudhuri A, Munschauer F, et al: Hyperglycemia, insulin, and acute ischemic stroke: A mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37:267-273
58. Demchuk AM, Morgenstern LB, Krieger DW, et al: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999; 30:34-39
59. Fogelholm R, Murros K, Rissanen A, et al: Admission blood glucose and short term survival in primary intracerebral haemorrhage: A population based study. J Neurol Neurosurg Psychiatr 2005; 76:349-353
60. Bilotta F, Spinelli A, Giovannini F, et al: The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: A randomized prospective pilot trial. J Neurosurg Anesthesiol 2007; 19:156-160
61. Pasternak JJ, McGregor DG, Schroeder DR, et al; IHAST Investigators: Hyperglycemia in patients undergoing cerebral aneurysm surgery: Its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc 2008; 83:406-417
62. Kruyt ND, Biessels GJ, de Haan RJ, et al: Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: A meta-analysis. Stroke 2009; 40:e424-e430
63. Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000; 46:335-342; discussion 342
64. Jeremitsky E, Omert LA, Dunham CM, et al: The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005; 58:47-50
65. Coester A, Neumann CR, Schmidt MI: Intensive insulin therapy in severe traumatic brain injury: A randomized trial. J Trauma 2010; 68:904-911
66. Baird TA, Parsons MW, Phanh T, et al: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34:2208-2214
67. Gentile NT, Seftchick MW, Huynh T, et al: Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13:174-180
68. Scott JF, Robinson GM, French JM, et al: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The Glucose Insulin in Stroke Trial (GIST). Stroke 1999; 30:793-799
69. Bruno A, Saha C, Williams LS, et al: IV insulin during acute cerebral infarction in diabetic patients. Neurology 2004; 62:1441-1442
70. Bell DA, Strong AJ: Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: A feasibility study. Br J Neurosurg 2005; 19:21-24
71. Walters MR, Weir CJ, Lees KR: A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006; 22:116-122
72. Gray CS, Hildreth AJ, Sandercock PA, et al; GIST Trialists Collaboration: Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: The UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007; 6: 397-406
73. Bilotta F, Caramia R, Cernak I, et al: Intensive insulin therapy after severe traumatic brain injury: A randomized clinical trial. Neurocrit Care 2008; 9:159-166
74. Bilotta F, Caramia R, Paoloni FP, et al: Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009; 110:611-619
75. Thiele RH, Pouratian N, Zuo Z, et al: Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology 2009; 110:603-610
76. Zhu CZ, Auer RN: Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg 2004; 101:664-668
77. Oddo M, Schmidt JM, Carrera E, et al: Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: A microdialysis study. Crit Care Med 2008; 36:3233-3238
78. Helbok R, Schmidt JM, Kurtz P, et al: Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care 2010; 12:317-323
79. Kosiborod M, Inzucchi SE, Goyal A, et al: Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009; 301:1556-1564
80. Arabi YM, Tamim HM, Rishu AH: Hypoglycemia with intensive insulin therapy in critically ill patients: Predisposing factors and association with mortality. Crit Care Med 2009; 37:2536-2544
81. Vriesendorp TM, van Santen S, DeVries JH, et al: Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34:96-101
82. Krinsley JS, Grover A: Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007; 35: 2262-2267
83. Vriesendorp TM, DeVries JH, van Santen S, et al: Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006; 34: 2714-2718
84. Van den Berghe G, Wilmer A, Milants I, et al: Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes 2006; 55:3151-3159
85. Egi M, Bellomo R, Stachowski E, et al: Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010; 85: 217-224
86. Bagshaw SM, Bellomo R, Jacka MJ, et al: The impact of early hypoglycemia and blood glucose variability on the outcome of critical illness. Crit Care 2009; 13:R91
87. Krinsley JS, Schultz MJ, Spronk PE, et al: Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care 2011; 15:R173
88. Meyfroidt G, Keenan DM, Wang X, et al: Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010; 38:1021-1029
89. Malouf R, Brust JC: Hypoglycemia: Causes, neurological manifestations, and outcome. Ann Neurol 1985; 17:421-430
90. Ben-Ami H, Nagachandran P, Mendelson A, et al: Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 1999; 159:281-284
91. Duning T, Ellger B: Is hypoglycaemia dangerous? Best Pract Res Clin Anaesthesiol 2009; 23:473-485
92. Malone JI, Hanna S, Saporta S, et al: Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 2008; 9:531-539
93. Suh SW, Gum ET, Hamby AM, et al: Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007; 117:910-918
94. Balentine JR, Gaeta TJ, Kessler D, et al: Effect of 50 milliliters of 50% dextrose in water administration on the blood sugar of euglycemic volunteers. Acad Emerg Med 1998; 5:691-694
95. Davidson PC, Steed RD, Bode BW: Glucommander: A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 2005; 28:2418-2423
96. Dortch MJ, Mowery NT, Ozdas A, et al: A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr 2008; 32:18-27
97. Juneja R, Roudebush CP, Nasraway SA, et al: Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time. Crit Care 2009; 13:R163
98. Moore C, Woollard M: Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital? A randomised controlled trial. Emerg Med J 2005; 22:512-515
99. Bhatia A, Cadman B, Mackenzie I: Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control. Anesth Analg 2006; 102:549-551
100. Carstens S, Sprehn M: Prehospital treatment of severe hypoglycaemia: A comparison of intramuscular glucagon and intravenous glucose. Prehosp Disaster Med 1998; 13:44-50
101. Slama G, Traynard PY, Desplanque N, et al: The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solutin, or gel for the correction of insulin reactions. Arch Intern Med 1990; 150:589-593
102. Vogelzang M, Loef BG, Regtien JG, et al: Computer-assisted glucose control in critically ill patients. Intensive Care Med 2008; 34:1421-1427
103. Scott MG, Bruns DE, Boyd JC, et al: Tight glucose control in the intensive care unit: Are glucose meters up to the task? Clin Chem 2009; 55:18-20
104. Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory Standards) Web site. Available at: http://www.clsi.org. Accessed January 7, 2011
105. Critchell CD, Savarese V, Callahan A, et al: Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med 2007; 33:2079-2084
106. Karon BS, Boyd JC, Klee GG: Glucose meter performance criteria for tight glycemic control estimated by simulation modeling. Clin Chem 2010; 56:1091-1097
107. Dungan K, Chapman J, Braithwaite SS, et al: Glucose measurement: Confounding issues in setting targets for inpatient management. Diabetes Care 2007; 30:403-409
108. Tang Z, Louie RF, Payes M, et al: Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther 2000; 2:349-362
109. Tang Z, Louie RF, Lee JH, et al: Oxygen effects on glucose meter measurements with glucose dehydrogenase-and oxidase-based test strips for point-of-care testing. Crit Care Med 2001; 29:1062-1070
110. Mann EA, Salinas J, Pidcoke HF, et al: Error rates resulting from anemia can be corrected in multiple commonly used point-of-care glucometers. J Trauma 2008; 64:15-20; discussion 20
111. Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA, et al: Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 2008; 36:3062-3066
112. Hoedemaekers CW, Klein Gunnewiek JM, Van der Hoeven JG: Point-of-care glucose measurement systems should be used with great caution in critically ill intensive care unit patients. Crit Care Med 2010; 38:339; author reply 339-339; author reply 340
113. Tang Z, Lee JH, Louie RF, et al: Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med 2000; 124:1135-1140
114. Louie RF, Tang Z, Sutton DV, et al: Point-of-care glucose testing: Effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med 2000; 124:257-266
115. Holtzinger C, Szelag E, DuBois JA, et al: Evaluation of a new POCT bedside glucose meter and strip with hematocrit and interference corrections. Point of Care 2008; 7:1-6
116. Biljak VR, Božievi S, Lovreni MV, et al: Performance of the Statstrip glucose meter in inpatient management of diabetes mellitus. Diabetol Croat 2010; 39:105-110
117. Pidcoke HF, Wade CE, Mann EA, et al: Anemia causes hypoglycemia in intensive care unit patients due to error in single-channel glucometers: Methods of reducing patient risk. Crit Care Med 2010; 38:471-476
118. Lopez C, Serrano LdL, Rodriquez R, et al: Validation of a glucose meters at an intensive care unit. Endocrinol Nutr 2012; 59:28-34
119. Tang Z, Du X, Louie RF, et al: Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol 2000; 113:75-86
120. Scott RJ, Deobald G, Griesmann L, et al: Evaluation of multiple whole blood glucose Methods compared with a laboratory plasma hexokinase reference assay. Point of Care 2008; 7:43-46
121. Abbott Laboratories Web site: Product info: cartridge and test information sheets. Available at: http://www.i-stat.com/products/ctisheets/ 714177-01H.pdf. Accessed July 15, 2012
122. Mahoney JJ, Ellison JM: Assessing glucose monitor performance-A standardized approach. Diabetes Technol Ther 2007; 9:545-552
123. Meynaar IA, van Spreuwel M, Tangkau PL, et al: Accuracy of AccuChek glucose measurement in intensive care patients. Crit Care Med 2009; 37:2691-2696
124. Cook A, Laughlin D, Moore M, et al: Differences in glucose values obtained from point-of-care glucose meters and laboratory analysis in critically ill patients. Am J Crit Care 2009; 18:65-71; quiz 72
125. Finkielman JD, Oyen LJ, Afessa B: Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest 2005; 127:1749-1751
126. Lacara T, Domagtoy C, Lickliter D, et al: Comparison of point-of-care and laboratory glucose analysis in critically ill patients. Am J Crit Care 2007; 16:336-346; quiz 347
127. Atkin SH, Dasmahapatra A, Jaker MA, et al: Fingerstick glucose determination in shock. Ann Intern Med 1991; 114: 1020-1024
128. Kulkarni A, Saxena M, Price G, et al: Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Med 2005; 31:142-145
129. Karon BS, Gandhi GY, Nuttall GA, et al: Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol 2007; 127: 919-926
130. Kanji S, Buffie J, Hutton B, et al: Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005; 33:2778-2785
131. Meex C, Poncin J, Chapelle JP, et al: Analytical validation of the new plasma calibrated Accu-Chek Test Strips (Roche Diagnostics). Clin Chem Lab Med 2006; 44:1376-1378
132. Ray JG, Hamielec C, Mastracci T: Pilot study of the accuracy of bedside glucometry in the intensive care unit. Crit Care Med 2001; 29:2205-2207
133. Corstjens AM, Ligtenberg JJ, van der Horst IC, et al: Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care 2006; 10:R135
134. Boyd R, Leigh B, Stuart P: Capillary versus venous bedside blood glucose estimations. Emerg Med J 2005; 22:177-179
135. Desachy A, Vuagnat AC, Ghazali AD, et al: Accuracy of bedside glucometry in critically ill patients: Influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008; 83:400-405
136. Yatabe T, Yamazaki R, Kitagawa H, et al: The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients. Crit Care Med 2011; 39:575-578
137. Kondepati VR, Heise HM: Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients. Anal Bioanal Chem 2007; 388:545-563
138. Aye T, Block J, Buckingham B: Toward closing the loop: An update on insulin pumps and continuous glucose monitoring systems. Endocrinol Metab Clin North Am 2010; 39:609-624
139. Klonoff DC, Buckingham B, Christiansen JS, et al; Endocrine Society: Continuous glucose monitoring: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96:2968-2979
140. Holzinger U, Warszawska J, Kitzberger R, et al: Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med 2009; 35:1383-1389
141. Siegelaar SE, Barwari T, Hermanides J, et al: Accuracy and reliability of continuous glucose monitoring in the intensive care unit: A head-to-head comparison of two subcutaneous glucose sensors in cardiac surgery patients. Diabetes Care 2011; 34:e31
142. Ellmerer M, Haluzik M, Blaha J, et al: Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care 2006; 29:1275-1281
143. Yamashita K, Okabayashi T, Yokoyama T, et al: The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 2008; 106:160-163, table of contents
144. Piper HG, Alexander JL, Shukla A, et al: Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics 2006; 118:1176-1184
145. Bridges BC, Preissig CM, Maher KO, et al: Continuous glucose monitors prove highly accurate in critically ill children. Crit Care 2010; 14:R176
146. Greenwood BC, Chesnick MA, Szumita PM, et al: Stability of regular human insulin extemporaneously prepared in 0.9% sodium chloride in a polyvinyl chloride bag. Hosp Pharm 2012; 47:367-370
147. Goldberg PA, Kedves A, Walter K, et al: "Waste not, want not": Determining the optimal priming volume for intravenous insulin infusions. Diabetes Technol Ther 2006; 8:598-601
148. Hellman R: Patient safety and inpatient glycemic control: Translating concepts into action. Endocr Pract 2006; 12(Suppl 3):49-55
149. Newton CA, Smiley D, Bode BW, et al: A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. standard column-based algorithms. J Hosp Med 2010; 5:432-437
150. Prescribing information, Apidra: Available at: http://products.sanofi.us/ apidra/apidra.pdf. Accessed March 18, 2012
151. Nerenberg KA, Goyal AA, Xavier D, et al: Piloting a novel algorithm for glucose control in the coronary care unit. Diab Care 2012; 35:19-24
152. Taylor BE, Schallom ME, Sona CS, et al: Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg 2006; 202:1-9
153. Eigsti J, Henke K: Innovative solutions: Development and implementation of a tight blood glucose management protocol: One community hospital's experience. Dimens Crit Care Nurs 2006; 25:62-65
154. Furnary AP, Braithwaite SS: Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006; 98:557-564
155. Grainger A, Eiden K, Kemper J, et al: A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit. Nutr Clin Pract 2007; 22:545-552
156. O'Malley CW, Emanuele M, Halasyamani L, et al: Bridge over troubled waters: Safe and effective transitions of the inpatient with hyperglycemia. J Hosp Med 2008; 3(Suppl 5):S55-S65
157. Ramos P, Childers D, Maynard G, et al: Maintaining glycemic control when transitioning from infusion insulin: A protocol-driven, multidisciplinary approach. J Hosp Med 2010; 5:446-451
158. Schmeltz LR, DeSantis AJ, Schmidt K, et al: Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract 2006; 12:641-650
159. Donaldson S, Villanuueva G, Rondinelli L, et al: Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: Elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ 2006; 32:954-962
160. Datta S, Qaadir A, Villanueva G, et al: Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: A randomized clinical trial. Endocr Pract 2007; 13:225-231
161. Yeldandi RR, Lurie A, Baldwin D: Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery. Diabetes Technol Ther 2006; 8:609-616
162. Korytkowski MT, Salata RJ, Koerbel GL, et al: Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: A randomized controlled clinical trial. Diabetes Care 2009; 32:594-596
163. Lepore M, Pampanelli S, Fanelli C, et al: Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000; 49:2142-2148
164. Weant KA, Ladha A: Conversion from continuous insulin infusions to subcutaneous insulin in critically ill patients. Ann Pharmacother 2009; 43:629-634
165. Martindale RG, McClave SA, Vanek VW, et al; American College of Critical Care Medicine; A.S.P.E.N. Board of Directors: Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med 2009; 37:1757-1761
166. Casaer MP, Mesotten D, Hermans G, et al: Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011; 365:506-517
167. Clayton SB, Mazur JE, Condren S, et al: Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med 2006; 34:2974-2978
168. Dickerson RN, Swiggart CE, Morgan LM, et al: Safety and efficacy of a graduated intravenous insulin infusion protocol in critically ill trauma patients receiving specialized nutritional support. Nutrition 2008; 24:536-545
169. Lonergan T, Compte AL, Willacy M, et al: A pilot study of the SPRINT protocol for tight glycemic control in critically ill patients. Diabetes Technol Ther 2006; 8:449-462
170. Chase JG, Shaw G, Le Compte A, et al: Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: A clinical practice change. Crit Care 2008; 12:R49
171. Hellman R: A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract 2004; 10(Suppl 2):100-108
172. Bates D, Clark NG, Cook RI, et al; Writing Committee on Patient Safety and Medical System Errors in Diabetes and Endocrinology: American College of Endocrinology and American Association of Clinical Endocrinologists position statement on patient safety and medical system errors in diabetes and endocrinology. Endocr Pract 2005; 11:197-202
173. Schleis TG: Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy 2007; 27:1313-1321
174. Sinha S, Jayaram R, Hargreaves CG: Fatal neuroglycopaenia after accidental use of a glucose 5% solution in a peripheral arterial cannula flush system. Anaesthesia 2007; 62:615-620
175. Eslami SAbu-Hanna A, de Jonge E, de Keizer NF: Tight glycemic control and computerized decision-support systems: A systematic review. Intensive Care Med 2009; 35:1505-1517
176. Blaha J, Kopecky P, Matias M, et al: Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care 2009; 32:757-761
177. Cavalcanti AB, Silva E, Pereira AJ, et al: A randomized controlled trial comparing a computer-assisted insulin infusion protocol with a strict and a conventional protocol for glucose control in critically ill patients. J Crit Care 2009; 24:371-378
178. Plank J, Blaha J, Cordingley J, et al: Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006; 29:271-276
179. Brown G, Dodek P: Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med 2001; 29:1714-1719
180. Kanji S, Singh A, Tierney M, et al: Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 2004; 30:804-810
181. Goldberg PA, Siegel MD, Sherwin RS, et al: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27:461-467
182. Quinn JA, Snyder SL, Berghoff JL, et al: A practical approach to hyperglycemia management in the intensive care unit: Evaluation of an intensive insulin infusion protocol. Pharmacotherapy 2006; 26:1410-1420
183. Wilson M, Weinreb J, Hoo GW: Intensive insulin therapy in critical care: A review of 12 protocols. Diabetes Care 2007; 30:1005-1011
184. Juneja R, Roudebush C, Kumar N, et al: Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther 2007; 9:232-240
185. Osburne RC, Cook CB, Stockton L, et al: Improving hyperglycemia management in the intensive care unit: Preliminary report of a nurse-driven quality improvement project using a redesigned insulin infusion algorithm. Diabetes Educ 2006; 32:394-403
186. Anabtawi A, Hurst M, Titi M, et al: Incidence of hypoglycemia with tight glycemic control protocols: A comparative study. Diabetes Technol Ther 2010; 12:635-639
187. Pielmeier U, Andreassen S, Juliussen B, et al: The Glucosafe system for tight glycemic control in critical care: A pilot evaluation study. J Crit Care 2010; 25:97-104
188. Cordingley JJ, Vlasselaers D, Dormand NC, et al: Intensive insulin therapy: Enhanced Model Predictive Control algorithm versus standard care. Intensive Care Med 2009; 35:123-128
189. Campion TR Jr, May AK, Waitman LR, et al: Effects of blood glucose transcription mismatches on a computer-based intensive insulin therapy protocol. Intensive Care Med 2010; 36:1566-1570
190. Cyrus RM, Szumita PM, Greenwood BC, et al: Evaluation of compliance with a paper-based, multiplication-factor, intravenous insulin protocol. Ann Pharmacother 2009; 43:1413-1418
191. Anger KE, Szumita PM: Barriers to glucose control in the intensive care unit. Pharmacotherapy 2006; 26:214-228
192. Dossett LA, Cao H, Mowery NT, et al: Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008; 74:679-85; discussion 685
193. Ali NA, O'Brien JM Jr, Dungan K, et al: Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36:2316-2321
194. Hirshberg E, Larsen G, Van Duker H: Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008; 9:361-366
195. Eslami S, de Keizer NF, de Jonge E, et al: A systematic review on quality indicators for tight glycaemic control in critically ill patients: Need for an unambiguous indicator reference subset. Crit Care 2008; 12:R139
196. Ali NA, Krinsley JS, Preiser JC: Glucose variability in critically ill patients. In: Yearbook of Intensive Care and Emergency Medicine. Vincent JL (Ed.). Berlin, Heidelberg, Springer-Verlag, 2009, pp 728-737
197. Risso A, Mercuri F, Quagliaro L, et al: Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001; 281:E924-E930
198. Quagliaro L, Piconi L, Assaloni R, et al: Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase C and NAD(P) H-oxidase activation. Diabetes 2003; 52: 2795-2804
199. Otto NM, Schindler R, Lun A, et al: Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro. Crit Care 2008; 12:R107
200. Goldberg PA, Bozzo JE, Thomas PG, et al: "Glucometrics"- Assessing the quality of inpatient glucose management. Diabetes Technol Ther 2006; 8:560-569
201. Braithwaite SS: Patient-level glucose reporting: Averages, episodes, or something in between? Crit Care 2008; 12:133
202. Schnipper JL, Magee M,Larsen K, et al: Society of Hospital Medicine Glycemic Control Task Force Summary: Practical recommendations for assessing the impact of glycemic control efforts. J Hosp Med 2008; 3 (Suppl 5):s66-s83
203. Furnary AP, Wu Y, Bookin SO: Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project. Endocr Pract 2004; 10(Suppl 2):21-33
204. Vogelzang M, van der Horst IC, Nijsten MW: Hyperglycaemic index as a tool to assess glucose control: A retrospective study. Crit Care 2004; 8:R122-R127
205. Estrada CA, Young JA, Nifong LW, et al: Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003; 75:1392-1399
206. Newton CA, Young S: Financial implications of glycemic control: Results of an inpatient diabetes management program. Endocr Pract 2006; 12(Suppl 3):43-48
207. Aragon D: Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006; 15:370-377
208. Malesker MA, Foral PA, McPhillips AC, et al: An efficiency evaluation of protocols for tight glycemic control in intensive care units. Am J Crit Care 2007; 16:589-598
209. Van den Berghe G, Wouters PJ, Kesteloot K, et al: Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 2006; 34:612-616
210. Krinsley JS, Jones RL: Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006; 129:644-650
211. Sadhu AR, Ang AC, Ingram-Drake LA, et al: Economic benefits of intensive insulin therapy in critically ill patients: The targeted insulin therapy to improve hospital outcomes (TRIUMPH) project. Diabetes Care 2008; 31:1556-1561
212. Hirshberg E, Lacroix J, Sward K, et al: Blood glucose control in critically ill adults and children: A survey on stated practice. Chest 2008; 133:1328-1335
213. Preissig CM, Rigby MR: A disparity between physician attitudes and practice regarding hyperglycemia in pediatric intensive care units in the United States: A survey on actual practice habits. Crit Care 2010; 14:R11
214. Vlasselaers D, Milants I, Desmet L, et al: Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373:547-556
215. Preissig CM, Hansen I, Roerig PL, et al: A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit. Pediatr Crit Care Med 2008; 9:581-588
216. Verhoeven JJ, Brand JB, van de Polder MM, et al: Management of hyperglycemia in the pediatric intensive care unit; implementation of a glucose control protocol. Pediatr Crit Care Med 2009; 10: 648-652
217. Preissig CM, Rigby MR, Maher KO: Glycemic control for postoperative pediatric cardiac patients. Pediatr Cardiol 2009; 30:1098-1104
218. Faraon-Pogaceanu C, Banasiak KJ, Hirshberg EL, et al: Management of hyperglycemia in the pediatric intensive care unit; implementation of a glucose control protocol. Pediatr Crit Care Med 2010; 11:741-749
219. Branco RG, Chavan A, Tasker RC: Pilot evaluation of continuous subcutaneous glucose monitoring in children with multiple organ dysfunction syndrome. Pediatr Crit Care Med 2010; 11:415-419
220. Steil GM, Deiss D, Shih J, et al: ICU insulin delivery algorithms: Why so many? How to choose? Diab Sci Tech 2009; 3:125-140
221. Steil GM, Langer M, Jaeger K, et al: Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control. Pediatr Crit Care Med 2011; 12:643-648
222. Agus MSD, Steil GM, Wypij D, et al: Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012; 367:1208-1219